Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Cystatin C Monoclonal Antibody (Cyst24)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA181910
Description
Mouse anti human Cystatin C antibody, clone Cyst24 detects human Cystatin C, a member of the type 2 cystatin superfamily.
Cystatin C, a member of the type 2 cystatin superfamily, is a potent inhibitor of cysteine proteinases, both endogenous (lysosomal cathepsins), and pathogenic. Cystatin C is a 13 kDa secreted protein which is found in high concentrations in biological fluids and is thought to be expressed by all human nucleated cells. Changes in Cystatin C have been documented in a number of cardiovascular diseases, including atherosclerosis, amyloid angiopathy and myocardial infarction. Its low molecular weight also means that Cystatin C can be used as a marker of renal failure.
Specifications
Cystatin C | |
Monoclonal | |
1 mg/mL | |
PBS with <0.1% sodium azide; pH 7.4 | |
P01034 | |
Cst3 | |
Proprietary Immunogen. | |
200 μg | |
Primary | |
Human | |
Antibody | |
IgG1 |
ELISA | |
Cyst24 | |
Unconjugated | |
Cst3 | |
AD8; ARMD11; bA218C14.4 (cystatin C); CST3; CYSC; cystatin; cystatin 3; cystatin C; cystatin C (amyloid angiopathy and cerebral hemorrhage); Cystatin C (cysteine proteinase inhibitor); Cystatin3; cystatin-3; CystatinC; Cystatin-C; epididymis secretory protein Li 2; fb51d07; Gamma-trace; HEL-S-2; MGC117328; neuroendocrine basic polypeptide; OTTHUMP00000030440; OTTHUMP00000164181; OTTHUMP00000164182; OTTMUSP00000016736; Post-gamma-globulin; RP23-250M11.9; wu:fb24g06; wu:fb51d07; wu:fc55f03; zgc:136227 | |
Mouse | |
Protein A | |
RUO | |
1471 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction